Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial

Abstract Introduction Products based on inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) combinations may provide different clinical benefits. This study was conducted to compare the rapid effects of three such combination products: formoterol/fluticasone (FFC) aerosol (pMDI), formoterol/b...

Full description

Bibliographic Details
Main Authors: Hiroyuki Ohbayashi, Sahori Kudo, Mitsue Ariga
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-09-01
Series:Pulmonary Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s41030-018-0062-x